Pulmonary hypertension, pulmonary embolism and COVID-19: A district general hospital experience from the UK. [PDF]
J R Coll Physicians Edinb, 2023 Mahdi N +6 more
europepmc +1 more source
Pediatric Pulmonary Hypertension
Journal of the American College of Cardiology, 2013 Pulmonary hypertension (PH) is a rare disease in newborns, infants, and children that is associated with significant morbidity and mortality. In the majority of pediatric patients, PH is idiopathic or associated with congenital heart disease and rarely is associated with other conditions such as connective tissue or thromboembolic disease.
Ivy, D Dunbar +11 more
openaire +6 more sources
The Pulmonary Hypertension Association Registry: Rationale, Design, and Role in Quality Improvement
, 2018 The Pulmonary Hypertension Association (PHA) Scientific Leadership Council (SLC) prioritized the development of the PH Care Centers (PHCC) initiative in part to identify centers that adhere to expert consensus diagnostic and treatment guidelines in both ...
Michael P. Gray, Steven M. Kawut
core +1 more source
Arthritis Care &Research, EarlyView.Objective Hospitalization, particularly for surgery, represents a period of heightened stress. We evaluated how frailty attenuates the association of rheumatoid arthritis (RA) with negative health outcomes after elective noncardiac surgery. Methods We conducted a cross‐sectional study using the National Inpatient Sample (2018 to 2020), including adults
Ali Yazdanyar +5 more
wiley +1 more source
Cellular senescence in adult pulmonary hypertension: current state and future challenges
European Respiratory ReviewPulmonary hypertension (PH) is a life-threatening disease increasingly being diagnosed in the elderly population, marked by vascular injury, excessive vasoconstriction and progressive remodelling of the pulmonary arteries (PAs).
Sarah-Eve Lemay +6 more
doaj +1 more source
Inoperable chronic thromboembolic pulmonary hypertension treated with riociguat: A case study
Revista Portuguesa de Cardiologia, 2015 A 51-year-old woman presented with a one-year history of progressive dyspnea, WHO functional class III-IV and exercise-related syncope. Transthoracic echocardiography and computed tomography pulmonary angiography were performed, leading to a diagnosis of
Carlos Ortiz-Bautista +4 more
doaj +1 more source
Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis. [PDF]
Front Cardiovasc Med, 2022 Hasan H +5 more
europepmc +1 more source
Pulmonary Hypertension in a Patient with Essential Thrombocythemia [PDF]
, 2002 A 67-year-old woman with essential thrombocythemia (ET) developed acute heart failure and marked pulmonary hypertension (PH). No clear cause for the PH could be initially found. We suspected that thrombocytosis might cause PH.
Miyahara, Yoshiyuki +6 more
core
Real‐World Safety of Concomitant Colchicine and Statin Therapy
Arthritis Care &Research, EarlyView.Objective This study aimed to evaluate the risk of clinically meaningful muscle‐ and liver‐related outcomes associated with concomitant colchicine–statin therapy in a real‐world setting, and to determine whether concomitant therapy increases the incidence of toxicity compared with either agent alone.
Roni Meidan +5 more
wiley +1 more source
Arthritis Care &Research, Accepted Article.Objective Existing patient‐reported outcome (PRO) measures for systemic sclerosis (SSc) have important limitations, including inadequate coverage of early disease and limited inclusion of diffuse cutaneous (dcSSc) and limited cutaneous (lcSSc) subtypes.
George J. Greene +5 more
wiley +1 more source